Table of Contents 1 Market Overview 1.1 Systemic Lupus Erythematous SLE Drug Introduction 1.2 Market Analysis by Type 1.2.1 Corticosteroids 1.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) 1.2.3 Anti-Inflammatories 1.2.4 Disease-Modifying Anti-Rheumatic Drugs (DMARDs) 1.2.5 Antimalarials 1.2.6 BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) 1.2.7 Immunosuppressive Agents/Immune Modulators 1.2.8 Anticoagulants 1.3 Market Analysis by Applications 1.3.1 Hospitals 1.3.2 Hospital Pharmacies 1.3.3 Drug Stores 1.3.4 Online Drug Stores 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Anthera Pharmaceuticals BMS 2.1.1 Business Overview 2.1.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 GSK 2.2.1 Business Overview 2.2.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 GSK Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 ImmuPharma 2.3.1 Business Overview 2.3.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 ImmuPharma Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Merck Serono 2.4.1 Business Overview 2.4.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Merck Serono Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 UCB 2.5.1 Business Overview 2.5.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 UCB Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Amgen 2.6.1 Business Overview 2.6.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Amgen Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 HGS 2.7.1 Business Overview 2.7.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 HGS Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Immunomedics 2.8.1 Business Overview 2.8.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Immunomedics Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 MedImmune 2.9.1 Business Overview 2.9.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 MedImmune Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Sanofi 2.10.1 Business Overview 2.10.2 Systemic Lupus Erythematous SLE Drug Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Sanofi Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Systemic Lupus Erythematous SLE Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Systemic Lupus Erythematous SLE Drug Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Systemic Lupus Erythematous SLE Drug Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Systemic Lupus Erythematous SLE Drug Manufacturer Market Share in 2017 3.3.2 Top 6 Systemic Lupus Erythematous SLE Drug Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Systemic Lupus Erythematous SLE Drug Market Analysis by Regions 4.1 Global Systemic Lupus Erythematous SLE Drug Sales, Revenue and Market Share by Regions 4.1.1 Global Systemic Lupus Erythematous SLE Drug Sales and Market Share by Regions (2013-2018) 4.1.2 Global Systemic Lupus Erythematous SLE Drug Revenue and Market Share by Regions (2013-2018) 4.2 North America Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 4.3 Europe Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 4.5 South America Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 5 North America Systemic Lupus Erythematous SLE Drug by Countries 5.1 North America Systemic Lupus Erythematous SLE Drug Sales, Revenue and Market Share by Countries 5.1.1 North America Systemic Lupus Erythematous SLE Drug Sales and Market Share by Countries (2013-2018) 5.1.2 North America Systemic Lupus Erythematous SLE Drug Revenue and Market Share by Countries (2013-2018) 5.2 United States Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 5.3 Canada Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 5.4 Mexico Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 6 Europe Systemic Lupus Erythematous SLE Drug by Countries 6.1 Europe Systemic Lupus Erythematous SLE Drug Sales, Revenue and Market Share by Countries 6.1.1 Europe Systemic Lupus Erythematous SLE Drug Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Systemic Lupus Erythematous SLE Drug Revenue and Market Share by Countries (2013-2018) 6.2 Germany Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 6.3 UK Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 6.4 France Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 6.5 Russia Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 6.6 Italy Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 7 Asia-Pacific Systemic Lupus Erythematous SLE Drug by Countries 7.1 Asia-Pacific Systemic Lupus Erythematous SLE Drug Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Systemic Lupus Erythematous SLE Drug Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Systemic Lupus Erythematous SLE Drug Revenue and Market Share by Countries (2013-2018) 7.2 China Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 7.3 Japan Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 7.4 Korea Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 7.5 India Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 8 South America Systemic Lupus Erythematous SLE Drug by Countries 8.1 South America Systemic Lupus Erythematous SLE Drug Sales, Revenue and Market Share by Countries 8.1.1 South America Systemic Lupus Erythematous SLE Drug Sales and Market Share by Countries (2013-2018) 8.1.2 South America Systemic Lupus Erythematous SLE Drug Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 8.3 Argentina Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 8.4 Colombia Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 9 Middle East and Africa Systemic Lupus Erythematous SLE Drug by Countries 9.1 Middle East and Africa Systemic Lupus Erythematous SLE Drug Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Systemic Lupus Erythematous SLE Drug Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Systemic Lupus Erythematous SLE Drug Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 9.3 UAE Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 9.4 Egypt Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 9.5 Nigeria Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 9.6 South Africa Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) 10 Global Systemic Lupus Erythematous SLE Drug Market Segment by Type 10.1 Global Systemic Lupus Erythematous SLE Drug Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Systemic Lupus Erythematous SLE Drug Sales and Market Share by Type (2013-2018) 10.1.2 Global Systemic Lupus Erythematous SLE Drug Revenue and Market Share by Type (2013-2018) 10.2 Corticosteroids Sales Growth and Price 10.2.1 Global Corticosteroids Sales Growth (2013-2018) 10.2.2 Global Corticosteroids Price (2013-2018) 10.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Sales Growth and Price 10.3.1 Global Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Sales Growth (2013-2018) 10.3.2 Global Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Price (2013-2018) 10.4 Anti-Inflammatories Sales Growth and Price 10.4.1 Global Anti-Inflammatories Sales Growth (2013-2018) 10.4.2 Global Anti-Inflammatories Price (2013-2018) 10.5 Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Sales Growth and Price 10.5.1 Global Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Sales Growth (2013-2018) 10.5.2 Global Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Price (2013-2018) 10.6 Antimalarials Sales Growth and Price 10.6.1 Global Antimalarials Sales Growth (2013-2018) 10.6.2 Global Antimalarials Price (2013-2018) 10.7 BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) Sales Growth and Price 10.7.1 Global BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) Sales Growth (2013-2018) 10.7.2 Global BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) Price (2013-2018) 10.8 Immunosuppressive Agents/Immune Modulators Sales Growth and Price 10.8.1 Global Immunosuppressive Agents/Immune Modulators Sales Growth (2013-2018) 10.8.2 Global Immunosuppressive Agents/Immune Modulators Price (2013-2018) 10.9 Anticoagulants Sales Growth and Price 10.9.1 Global Anticoagulants Sales Growth (2013-2018) 10.9.2 Global Anticoagulants Price (2013-2018) 11 Global Systemic Lupus Erythematous SLE Drug Market Segment by Application 11.1 Global Systemic Lupus Erythematous SLE Drug Sales Market Share by Application (2013-2018) 11.2 Hospitals Sales Growth (2013-2018) 11.3 Hospital Pharmacies Sales Growth (2013-2018) 11.4 Drug Stores Sales Growth (2013-2018) 11.5 Online Drug Stores Sales Growth (2013-2018) 12 Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) 12.1 Global Systemic Lupus Erythematous SLE Drug Sales, Revenue and Growth Rate (2018-2023) 12.2 Systemic Lupus Erythematous SLE Drug Market Forecast by Regions (2018-2023) 12.2.1 North America Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) 12.2.2 Europe Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) 12.2.3 Asia-Pacific Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) 12.2.4 South America Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) 12.2.5 Middle East and Africa Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) 12.3 Systemic Lupus Erythematous SLE Drug Market Forecast by Type (2018-2023) 12.3.1 Global Systemic Lupus Erythematous SLE Drug Sales Forecast by Type (2018-2023) 12.3.2 Global Systemic Lupus Erythematous SLE Drug Market Share Forecast by Type (2018-2023) 12.4 Systemic Lupus Erythematous SLE Drug Market Forecast by Application (2018-2023) 12.4.1 Global Systemic Lupus Erythematous SLE Drug Sales Forecast by Application (2018-2023) 12.4.2 Global Systemic Lupus Erythematous SLE Drug Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Systemic Lupus Erythematous SLE Drug Picture Table Product Specifications of Systemic Lupus Erythematous SLE Drug Figure Global Sales Market Share of Systemic Lupus Erythematous SLE Drug by Types in 2017 Table Systemic Lupus Erythematous SLE Drug Types for Major Manufacturers Figure Corticosteroids Picture Figure Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Picture Figure Anti-Inflammatories Picture Figure Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Picture Figure Antimalarials Picture Figure BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) Picture Figure Immunosuppressive Agents/Immune Modulators Picture Figure Anticoagulants Picture Figure Systemic Lupus Erythematous SLE Drug Sales Market Share by Applications in 2017 Figure Hospitals Picture Figure Hospital Pharmacies Picture Figure Drug Stores Picture Figure Online Drug Stores Picture Figure United States Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Canada Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Germany Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure France Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure UK Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Russia Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Italy Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure China Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Japan Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Korea Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure India Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Systemic Lupus Erythematous SLE Drug Revenue (Value) and Growth Rate (2013-2023) Table Anthera Pharmaceuticals BMS Basic Information, Manufacturing Base and Competitors Table Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Type and Applications Table Anthera Pharmaceuticals BMS Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GSK Basic Information, Manufacturing Base and Competitors Table GSK Systemic Lupus Erythematous SLE Drug Type and Applications Table GSK Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table ImmuPharma Basic Information, Manufacturing Base and Competitors Table ImmuPharma Systemic Lupus Erythematous SLE Drug Type and Applications Table ImmuPharma Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck Serono Basic Information, Manufacturing Base and Competitors Table Merck Serono Systemic Lupus Erythematous SLE Drug Type and Applications Table Merck Serono Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table UCB Basic Information, Manufacturing Base and Competitors Table UCB Systemic Lupus Erythematous SLE Drug Type and Applications Table UCB Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Amgen Basic Information, Manufacturing Base and Competitors Table Amgen Systemic Lupus Erythematous SLE Drug Type and Applications Table Amgen Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table HGS Basic Information, Manufacturing Base and Competitors Table HGS Systemic Lupus Erythematous SLE Drug Type and Applications Table HGS Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Immunomedics Basic Information, Manufacturing Base and Competitors Table Immunomedics Systemic Lupus Erythematous SLE Drug Type and Applications Table Immunomedics Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table MedImmune Basic Information, Manufacturing Base and Competitors Table MedImmune Systemic Lupus Erythematous SLE Drug Type and Applications Table MedImmune Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Systemic Lupus Erythematous SLE Drug Type and Applications Table Sanofi Systemic Lupus Erythematous SLE Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Systemic Lupus Erythematous SLE Drug Sales by Manufacturer (2016-2017) Figure Global Systemic Lupus Erythematous SLE Drug Sales Market Share by Manufacturer in 2016 Figure Global Systemic Lupus Erythematous SLE Drug Sales Market Share by Manufacturer in 2017 Table Global Systemic Lupus Erythematous SLE Drug Revenue by Manufacturer (2016-2017) Figure Global Systemic Lupus Erythematous SLE Drug Revenue Market Share by Manufacturer in 2016 Figure Global Systemic Lupus Erythematous SLE Drug Revenue Market Share by Manufacturer in 2017 Figure Top 3 Systemic Lupus Erythematous SLE Drug Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Systemic Lupus Erythematous SLE Drug Manufacturer (Revenue) Market Share in 2017 Figure Global Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Global Systemic Lupus Erythematous SLE Drug Revenue and Growth Rate (2013-2018) Table Global Systemic Lupus Erythematous SLE Drug Sales by Regions (2013-2018) Table Global Systemic Lupus Erythematous SLE Drug Sales Market Share by Regions (2013-2018) Table Global Systemic Lupus Erythematous SLE Drug Revenue by Regions (2013-2018) Figure Global Systemic Lupus Erythematous SLE Drug Revenue Market Share by Regions in 2013 Figure Global Systemic Lupus Erythematous SLE Drug Revenue Market Share by Regions in 2017 Figure North America Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Europe Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Asia-Pacific Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure South America Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Middle East and Africa Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure North America Systemic Lupus Erythematous SLE Drug Revenue and Growth Rate (2013-2018) Table North America Systemic Lupus Erythematous SLE Drug Sales by Countries (2013-2018) Table North America Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries (2013-2018) Figure North America Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries in 2013 Figure North America Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries in 2017 Table North America Systemic Lupus Erythematous SLE Drug Revenue by Countries (2013-2018) Table North America Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries (2013-2018) Figure North America Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries in 2013 Figure North America Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries in 2017 Figure United States Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Canada Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Mexico Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Europe Systemic Lupus Erythematous SLE Drug Revenue and Growth Rate (2013-2018) Table Europe Systemic Lupus Erythematous SLE Drug Sales by Countries (2013-2018) Table Europe Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries (2013-2018) Table Europe Systemic Lupus Erythematous SLE Drug Revenue by Countries (2013-2018) Figure Europe Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries in 2016 Figure Europe Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries in 2017 Figure Germany Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure UK Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure France Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Russia Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Italy Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Asia-Pacific Systemic Lupus Erythematous SLE Drug Revenue and Growth Rate (2013-2018) Table Asia-Pacific Systemic Lupus Erythematous SLE Drug Sales by Countries (2013-2018) Table Asia-Pacific Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries 2017 Table Asia-Pacific Systemic Lupus Erythematous SLE Drug Revenue by Countries (2013-2018) Figure Asia-Pacific Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries 2017 Figure China Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Japan Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Korea Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure India Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Southeast Asia Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure South America Systemic Lupus Erythematous SLE Drug Revenue and Growth Rate (2013-2018) Table South America Systemic Lupus Erythematous SLE Drug Sales by Countries (2013-2018) Table South America Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries (2013-2018) Figure South America Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries in 2017 Table South America Systemic Lupus Erythematous SLE Drug Revenue by Countries (2013-2018) Table South America Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries (2013-2018) Figure South America Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries in 2017 Figure Brazil Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Argentina Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Colombia Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Middle East and Africa Systemic Lupus Erythematous SLE Drug Revenue and Growth Rate (2013-2018) Table Middle East and Africa Systemic Lupus Erythematous SLE Drug Sales by Countries (2013-2018) Table Middle East and Africa Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Systemic Lupus Erythematous SLE Drug Sales Market Share by Countries in 2017 Table Middle East and Africa Systemic Lupus Erythematous SLE Drug Revenue by Countries (2013-2018) Table Middle East and Africa Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries in 2013 Figure Middle East and Africa Systemic Lupus Erythematous SLE Drug Revenue Market Share by Countries in 2017 Figure Saudi Arabia Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure UAE Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Egypt Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure Nigeria Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Figure South Africa Systemic Lupus Erythematous SLE Drug Sales and Growth Rate (2013-2018) Table Global Systemic Lupus Erythematous SLE Drug Sales by Type (2013-2018) Table Global Systemic Lupus Erythematous SLE Drug Sales Share by Type (2013-2018) Table Global Systemic Lupus Erythematous SLE Drug Revenue by Type (2013-2018) Table Global Systemic Lupus Erythematous SLE Drug Revenue Share by Type (2013-2018) Figure Global Corticosteroids Sales Growth (2013-2018) Figure Global Corticosteroids Price (2013-2018) Figure Global Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Sales Growth (2013-2018) Figure Global Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Price (2013-2018) Figure Global Anti-Inflammatories Sales Growth (2013-2018) Figure Global Anti-Inflammatories Price (2013-2018) Figure Global Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Sales Growth (2013-2018) Figure Global Disease-Modifying Anti-Rheumatic Drugs (DMARDs) Price (2013-2018) Figure Global Antimalarials Sales Growth (2013-2018) Figure Global Antimalarials Price (2013-2018) Figure Global BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) Sales Growth (2013-2018) Figure Global BLyS-specific Inhibitors or Monoclonal Antibodies (MAbS) Price (2013-2018) Figure Global Immunosuppressive Agents/Immune Modulators Sales Growth (2013-2018) Figure Global Immunosuppressive Agents/Immune Modulators Price (2013-2018) Figure Global Anticoagulants Sales Growth (2013-2018) Figure Global Anticoagulants Price (2013-2018) Table Global Systemic Lupus Erythematous SLE Drug Sales by Application (2013-2018) Table Global Systemic Lupus Erythematous SLE Drug Sales Share by Application (2013-2018) Figure Global Hospital Pharmacies Sales Growth (2013-2018) Figure Global Drug Stores Sales Growth (2013-2018) Figure Global Online Drug Stores Sales Growth (2013-2018) Figure Global Systemic Lupus Erythematous SLE Drug Sales, Revenue and Growth Rate (2018-2023) Table Global Systemic Lupus Erythematous SLE Drug Sales Forecast by Regions (2018-2023) Table Global Systemic Lupus Erythematous SLE Drug Market Share Forecast by Regions (2018-2023) Figure North America Sales Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) Figure Europe Sales Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) Figure Asia-Pacific Sales Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) Figure South America Sales Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) Figure Middle East and Africa Sales Systemic Lupus Erythematous SLE Drug Market Forecast (2018-2023) Table Global Systemic Lupus Erythematous SLE Drug Sales Forecast by Type (2018-2023) Table Global Systemic Lupus Erythematous SLE Drug Market Share Forecast by Type (2018-2023) Table Global Systemic Lupus Erythematous SLE Drug Sales Forecast by Application (2018-2023) Table Global Systemic Lupus Erythematous SLE Drug Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Anthera Pharmaceuticals BMS GSK ImmuPharma Merck Serono UCB Amgen HGS Immunomedics MedImmune Sanofi